Similar outcome of heart failure with reduced EF patients with and without atrial fibrillation: considerations from the ESC Heart Failure Long-Term Registry
Recently, transcatheter ablation of atrial fibrillation (AF) has been validated by international societal guidelines as a technique suitable for both treatment and secondary prevention of paroxysmal, persistent or long-lasting persistent AF in highly symptomatic patients in whom at least one antiar...
Main Author: | Renato De Vecchis |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-09-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/1061 |
Similar Items
-
Atrial fibrillation and heart failure- results of the CASTLE-AF trial
by: Syed Raza Shah, et al.
Published: (2018-07-01) -
Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice
by: João Pedro Ferreira, et al.
Published: (2015-01-01) -
Atrial Fibrillation Ablation in Heart Failure Patients
by: Michael Derndorfer, et al.
Published: (2021-08-01) -
Toward Mechanism-Directed Electrophenotype-Based Treatments for Atrial Fibrillation
by: Fu Siong Ng, et al.
Published: (2020-08-01) -
Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
by: Jae‐Sun Uhm, et al.
Published: (2021-04-01)